Skip to main content
. 2020 Nov 4;7(1):e000692. doi: 10.1136/bmjresp-2020-000692

Table 1.

Baseline characteristics of the patients in the case and control groups

Early group (controls) n=103 Late group (cases) n=103
CPAP (count) 3 (1 survived and two died) 15 (8 survived and seven died)
Mean A-a gradient at the start of CPAP 40.89 40.83
Mean A-a gradient at the end of CPAP 33.90 31.94
Mean A-a difference start/end 19.53 7.03
Median O2 for CPAP patients (kPa) NA 9.4
Median CO2 for CPAP patients (kPa) NA 4.8
Median FiO2 for CPAP patients NA 56.5
Intubated (count) 15 7
Average stay in hospital (until discharged) (days)* 8 12
Mean time in hospital until death (days) 9.2 7
Average age (years) 70.5 70.3
Average age at death (years) 74.9 76.1
Sex (count) 66 M / 37F 66 M / 37F
Deaths (count) 41 (34M/7F) 46 (35M/11F)
From care homes (count) 21 39
Diabetic (count) 23 35
Pulmonary (count) 35 22
With asthma 14 10
With emphysema 20 9
With bronchiectasis 3 5
Cardiac (count) 36 27
Renal (count) 10 7
Hypertension (count) 36 36
Average no of comorbidities per patient 1.37 1.23

A-A stands for alveolar–arterial gradient a measure of gas/exchange diffusion. Values of O2, CO2 and FiO2 for early group not reported since they were available for only one patient.

*Since confirmation of COVID-19.

CPAP, continuous positive air pressure; Fio2, fractional inspired oxygen; ICU, Intensive Care Unit; NA, not available.